Literature DB >> 16821145

Posttranslational phosphorylation of mutant p53 protein in tumor development.

Manabu Matsumoto1, Mutsuo Furihata, Yuji Ohtsuki.   

Abstract

p53 has been called the "cellular gatekeeper" and the "genome guard," because in response to exposure to DNA-damaging agents, it induces cell-cycle arrest in G1 or apoptosis and also directly affects DNA replication. Multiple mechanisms regulate p53 activity and posttranslational modification, including multisite phosphorylation of wild-type p53, in particular. Normal functions of wild-type p53 are abrogated by mutation of this gene, and oncogenic studies have revealed that p53 mutation is among the most common genetic alteration in human cancers. It is generally accepted that mutant p53 protein may not only lose the tumor suppressor functions of wild-type p53 but also acquire additional tumorigenetic roles, including dominant-negative effects and gain of function. Although many studies have revealed such aberrant functions of mutant p53, less is known about the posttranslational phosphorylation status of mutant p53 and novel biological functions of phosphorylation in carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16821145     DOI: 10.1007/s00795-006-0320-0

Source DB:  PubMed          Journal:  Med Mol Morphol        ISSN: 1860-1499            Impact factor:   2.309


  131 in total

1.  Direct interaction of p21 cyclin-dependent kinase inhibitor with the retinoblastoma tumor suppressor protein.

Authors:  M Nakanishi; Y Kaneko; H Matsushime; K Ikeda
Journal:  Biochem Biophys Res Commun       Date:  1999-09-16       Impact factor: 3.575

Review 2.  Cell cycle checkpoint signaling through the ATM and ATR kinases.

Authors:  R T Abraham
Journal:  Genes Dev       Date:  2001-09-01       Impact factor: 11.361

Review 3.  Oxygen(es) and the hypoxia-inducible factor-1.

Authors:  R H Wenger; M Gassmann
Journal:  Biol Chem       Date:  1997-07       Impact factor: 3.915

4.  Domain architecture of the p62 subunit from the human transcription/repair factor TFIIH deduced by limited proteolysis and mass spectrometry analysis.

Authors:  Anass Jawhari; Stéphanie Boussert; Valérie Lamour; R Andrew Atkinson; Bruno Kieffer; Olivier Poch; Noelle Potier; Alain van Dorsselaer; Dino Moras; Arnaud Poterszman
Journal:  Biochemistry       Date:  2004-11-16       Impact factor: 3.162

5.  Transcriptional activation by wild-type but not transforming mutants of the p53 anti-oncogene.

Authors:  L Raycroft; H Y Wu; G Lozano
Journal:  Science       Date:  1990-08-31       Impact factor: 47.728

6.  Localization of gene for human p53 tumour antigen to band 17p13.

Authors:  M Isobe; B S Emanuel; D Givol; M Oren; C M Croce
Journal:  Nature       Date:  1986 Mar 6-12       Impact factor: 49.962

7.  Identification of a p53-dependent negative response element in the bcl-2 gene.

Authors:  T Miyashita; M Harigai; M Hanada; J C Reed
Journal:  Cancer Res       Date:  1994-06-15       Impact factor: 12.701

8.  Two distinct regions of the murine p53 primary amino acid sequence are implicated in stable complex formation with simian virus 40 T antigen.

Authors:  J R Jenkins; P Chumakov; C Addison; H W Stürzbecher; A Wade-Evans
Journal:  J Virol       Date:  1988-10       Impact factor: 5.103

9.  Ataxia telangiectasia mutated (ATM) and ATM and Rad3-related protein exhibit selective target specificities in response to different forms of DNA damage.

Authors:  Christopher E Helt; William A Cliby; Peter C Keng; Robert A Bambara; Michael A O'Reilly
Journal:  J Biol Chem       Date:  2004-11-08       Impact factor: 5.157

Review 10.  TP53 tumor suppressor gene: a model for investigating human mutagenesis.

Authors:  C Caron de Fromentel; T Soussi
Journal:  Genes Chromosomes Cancer       Date:  1992-01       Impact factor: 5.006

View more
  23 in total

1.  Aurora A mediates cross-talk between N- and C-terminal post-translational modifications of p53.

Authors:  Lorna Jane Warnock; Sally Anne Raines; Jo Milner
Journal:  Cancer Biol Ther       Date:  2011-12-15       Impact factor: 4.742

Review 2.  Modelling the p53/p66Shc Aging Pathway in the Shortest Living Vertebrate Nothobranchius Furzeri.

Authors:  Chiara Priami; Giulia De Michele; Franco Cotelli; Alessandro Cellerino; Marco Giorgio; Pier Giuseppe Pelicci; Enrica Migliaccio
Journal:  Aging Dis       Date:  2015-03-10       Impact factor: 6.745

Review 3.  p53 regulation upon genotoxic stress: intricacies and complexities.

Authors:  Rajni Kumari; Saishruti Kohli; Sanjeev Das
Journal:  Mol Cell Oncol       Date:  2014-12-23

4.  Thymidylate synthase inhibition induces p53-dependent and p53-independent apoptotic responses in human urinary bladder cancer cells.

Authors:  Dimitrios J Stravopodis; Panagiotis K Karkoulis; Eumorphia G Konstantakou; Sophia Melachroinou; Angeliki Thanasopoulou; Gerasimos Aravantinos; Lukas H Margaritis; Ema Anastasiadou; Gerassimos E Voutsinas
Journal:  J Cancer Res Clin Oncol       Date:  2010-04-28       Impact factor: 4.553

5.  Age-dependent copy number variations of TP53 tumour suppressor gene associated with altered phosphorylation status of p53 protein in sporadic schwannomas.

Authors:  Hongsai Chen; He Huang; Jingjing Zhao; Zhigang Wang; Mengling Chang; Lu Xue; Weidong Zhu; Yongchuan Chai; Gen Li; Zhaoyan Wang; Hao Wu
Journal:  J Neurooncol       Date:  2019-05-02       Impact factor: 4.130

Review 6.  Mutant TP53 posttranslational modifications: challenges and opportunities.

Authors:  Thuy-Ai Nguyen; Daniel Menendez; Michael A Resnick; Carl W Anderson
Journal:  Hum Mutat       Date:  2014-02-11       Impact factor: 4.878

7.  Mycobacteria Manipulate G-Protein-Coupled Receptors to Increase Mucosal Rac1 Expression in the Lungs.

Authors:  Nader Alaridah; Nataliya Lutay; Erik Tenland; Anna Rönnholm; Oskar Hallgren; Manoj Puthia; Gunilla Westergren-Thorsson; Gabriela Godaly
Journal:  J Innate Immun       Date:  2016-12-24       Impact factor: 7.349

8.  Evolutionary Action Score of TP53 Coding Variants Is Predictive of Platinum Response in Head and Neck Cancer Patients.

Authors:  Abdullah A Osman; David M Neskey; Panagiotis Katsonis; Ameeta A Patel; Alexandra M Ward; Teng-Kuei Hsu; Stephanie C Hicks; Thomas O McDonald; Thomas J Ow; Marcus Ortega Alves; Curtis R Pickering; Heath D Skinner; Mei Zhao; Eric M Sturgis; Merrill S Kies; Adel El-Naggar; Federica Perrone; Lisa Licitra; Paolo Bossi; Marek Kimmel; Mitchell J Frederick; Olivier Lichtarge; Jeffrey N Myers
Journal:  Cancer Res       Date:  2015-02-17       Impact factor: 12.701

9.  Met acts through Abl to regulate p53 transcriptional outcomes and cell survival in the developing liver.

Authors:  Alessandro Furlan; Fabienne Lamballe; Venturina Stagni; Azeemudeen Hussain; Sylvie Richelme; Andrea Prodosmo; Anice Moumen; Christine Brun; Ivan Del Barco Barrantes; J Simon C Arthur; Anthony J Koleske; Angel R Nebreda; Daniela Barilà; Flavio Maina
Journal:  J Hepatol       Date:  2012-08-10       Impact factor: 25.083

Review 10.  p53 mutations in cancer.

Authors:  Patricia A J Muller; Karen H Vousden
Journal:  Nat Cell Biol       Date:  2013-01       Impact factor: 28.824

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.